Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes

OBJECTIVE: The main purpose of this study was to investigate the association of serum SerpinB1 levels and various parameters in patients with type 2 diabetes. The effect of canagliflozin (a sodium glucose cotransporter 2 (SGLT2) inhibitor), which can decrease circulating insulin levels, on serum Ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Takebayashi, Kohzo, Hara, Kenji, Terasawa, Tomoko, Naruse, Rika, Suetsugu, Mariko, Tsuchiya, Takafumi, Inukai, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128937/
https://www.ncbi.nlm.nih.gov/pubmed/27933185
http://dx.doi.org/10.1136/bmjdrc-2016-000274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128937/
https://www.ncbi.nlm.nih.gov/pubmed/27933185
http://dx.doi.org/10.1136/bmjdrc-2016-000274

Ejemplares similares